D-serine in Schizophrenia
NCT03702933 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2018-10-11
Summary
This study will assess the effects of D-serine adjuvant treatment to the ongoing pharmacological treatment of schizophrenia patients that are resistant to treatments.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
D-serine
dosage
Sponsors & Collaborators
-
Herzog Hospital
lead OTHER
Principal Investigators
-
Uriel Heresco-Levy, MD · Herzog Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-09-01
- Primary Completion
- 2021-09-01
- Completion
- 2021-12-01
Countries
- Israel
Study Locations
More Related Trials
-
D-serine for the Schizophrenia Prodrome
NCT00826202 ·Status: COMPLETED ·Phase: PHASE2
-
D-Serine Treatment For Tardive Dyskinesia
NCT01804920 ·Status: UNKNOWN ·Phase: NA
-
The Effect of D-serine as add-on Therapy in Recent-onset Psychosis
NCT04140773 ·Status: TERMINATED ·Phase: NA
-
D-serine Augmentation of Neuroplasticity
NCT03711500 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
D-Serine for Enhancing Cognitive Retraining for the Treatment of Schizophrenia
NCT00237848 ·Status: COMPLETED ·Phase: PHASE3
-
Creatine Treatment in Psychiatric Disorders
NCT00140192 ·Status: COMPLETED ·Phase: PHASE3
-
Vitamin D for Schizophrenia
NCT01759485 ·Status: COMPLETED ·Phase: NA
-
Sarcosine or D-Serine Add-on Treatment for Chronic Schizophrenia
NCT00491569 ·Status: COMPLETED ·Phase: PHASE2
-
Oxygen Therapy in Schizophrenia
NCT00525863 ·Status: UNKNOWN ·Phase: PHASE3
-
D-serine and Cognitive Remediation in Schizophrenia
NCT02156908 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of D-Cycloserine in Schizophrenia
NCT00000371 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of N-Acetyl Cysteine on Cortical Erosion in Early Stage Schizophrenia
NCT01339858 ·Status: COMPLETED ·Phase: PHASE4
-
Curcumin Addition to Antipsychotic Treatment in Chronic Schizophrenia Patients
NCT02298985 ·Status: COMPLETED ·Phase: PHASE4
-
Influence of Vitamin D Supplementation on Serum BDNF Level and Cognitive Function in Schizophrenia
NCT03284294 ·Status: UNKNOWN ·Phase: PHASE3
-
Dopamine Function and Reward Processing In Schizophrenia
NCT01035996 ·Status: COMPLETED
-
Adjunctive Treatment for Decreasing Symptoms of Schizophrenia
NCT00222235 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Sarcosine Preventive Therapy for Individuals At High Risk for Schizophrenia
NCT00276263 ·Status: WITHDRAWN ·Phase: PHASE2
-
The Antiatherogenic Properties of HDL in Psychiatric Patients With and Without Antipsychotic Therapy
NCT01215383 ·Status: UNKNOWN
-
The Effects AZD8529 on Cognition and Negative Symptoms in Schizophrenics
NCT00986531 ·Status: COMPLETED ·Phase: PHASE1
-
Entacapone Augmentation for Schizophrenia
NCT00192855 ·Status: COMPLETED ·Phase: NA
-
The Effects of Non-invasive Brain Stimulation on Treatment Adherence in Schizophrenia
NCT04033679 ·Status: RECRUITING ·Phase: NA
-
Transcranial Weak Current Stimulation Treatments for Working Memory Dysfunction in Schizophrenia
NCT04637724 ·Status: COMPLETED ·Phase: NA
-
Oxytocin as Adjunctive Treatment of Schizophrenia
NCT01568528 ·Status: COMPLETED ·Phase: PHASE2
-
Coronary Artery Disease in Patients Suffering From Schizophrenia
NCT02885792 ·Status: UNKNOWN ·Phase: NA
-
D-cycloserine Augmentation of Cognitive Remediation in Schizophrenia
NCT00963924 ·Status: COMPLETED ·Phase: NA